Open Access<p>Coronary Sinus Reducing Stent for the Treatment of Refractory Angina Pectoris: A Health Technology Assessment</p>
Author(s) -
Michal Stanak,
E. Rothschedl,
Piotr Szymański
Publication year - 2020
Publication title -
medical devices
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.482
H-Index - 30
ISSN - 1179-1470
DOI - 10.2147/mder.s255440
Subject(s) - medicine , canadian cardiovascular society , angina , adverse effect , randomized controlled trial , quality of life (healthcare) , clinical trial , refractory (planetary science) , stent , physical therapy , surgery , myocardial infarction , physics , nursing , astrobiology
To summarize the evidence on the clinical effectiveness and safety of coronary sinus reducing stent (CSRS) therapy in refractory angina pectoris (AP) patients.